Results for the substance tepotinib

Tepotinib is a tyrosine kinase inhibitor used for the treatment of advanced non-small cell lung cancer (NSCLC) associated with MET mutations. It works by blocking the activity of the MET receptor, thereby reducing the growth and spread of cancer cells.

The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and undergo regular medical check-ups to monitor the response to treatment.

Patients should be aware of potential side effects, such as nausea, edema, or elevated liver enzymes. It is important to inform the doctor of any unusual symptoms or the use of other medications.

Common side effects include nausea, edema, diarrhea, and elevated liver enzymes. In rare cases, severe reactions such as liver toxicity or allergic reactions may occur. Patients should be informed of these risks before starting treatment.